Skip to main content
Premium Trial:

Request an Annual Quote

BGI-Research, KeyGene Collaborate on Using Spatial Transcriptomics for Crop Sciences

NEW YORK – BGI-Research, part of the BGI Group in China, and Dutch agro-food research company KeyGene said on Tuesday that they have forged a collaboration to apply BGI-Research’s spatial transcriptomics technology for plant breeding.

Financial terms of the joint effort were not disclosed.

As part of the partnership, the companies said they will focus on identifying genes involved in the interaction between plants and pathogens using BGI Research’s recently introduced spatial enhanced resolution omics-sequencing (Stereo-Seq) technology.

"Such leads will form the basis for the development of crop varieties containing novel and durable resistances against pathogens, thus supporting sustainable food production around the globe," the firms said in a joint statement.

"Our collaboration with KeyGene gives us great opportunities to study the value of Stereo-Seq for plant research and plant breeding in industry and the academic world around the globe," said BGI-Research CEO Xiaodong Fang in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.